Allergic contact dermatitis to naftifine

Corazza, Monica; Lauriola, Maria Michela

doi:10.1111/j.0105-1873.2005.0654d.x

Search citation statements

Order By: Relevance

Paper Sections

Select...

Safety Profile Of Naftifine1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2006

2021

Publication Types

Select...

Book4

Article2

Relationship

Self Cite0

Independent6

Authors

Journals

Cited by 10 publications

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…2,3 Few cases of allergic contact dermatitis owing to naftifine have been presented in the English literature. [42][43][44][45] Dermatotoxicology studies in humans showed no evidence of irritancy, phototoxicity, sensitization, or photosensitization with naftifine. 46 Crossreactivity and cross-resistance of naftifine with other allylamines have rarely been a concern with naftifine use.…”

Section: Safety Profile Of Naftifinementioning

confidence: 99%

Naftifine: A Review

2008

View full text Add to dashboard Cite

show abstract

Section: Safety Profile Of Naftifinementioning

confidence: 99%

Naftifine: A Review

2008

View full text Add to dashboard Cite

show abstract

Current awareness: Pharmacoepidemiology and drug safety

2006

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of pharmacoepidemiology and drug safety. Each bibliography is divided into 20 sections: 1 Books, Reviews & Symposia; 2 General; 3 Anti‐infective Agents; 4 Cardiovascular System Agents; 5 CNS Depressive Agents; 6 Non‐steroidal Anti‐inflammatory Agents; 7 CNS Agents; 8 Anti‐neoplastic Agents; 9 Haematological Agents; 10 Neuroregulator‐Blocking Agents; 11 Dermatological Agents; 12 Immunosuppressive Agents; 13 Autonomic Agents; 14 Respiratory System Agents; 15 Neuromuscular Agents; 16 Reproductive System Agents; 17 Gastrointestinal System Agents; 18 Anti‐inflammatory Agents ‐ Steroidal; 19 Teratogens/fetal exposure; 20 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.

show abstract